Table 1 Comparison of general clinical characteristics between the training and validation sets.

From: Nomogram for predicting postpartum hemorrhage in women with hypertensive disorders of pregnancy

Variables

Training set (n = 336)

Validation set (n = 144)

χ2/t

P

PPH

  

0.212

0.645

No

254 (75.6%)

106 (73.6%)

  

Yes

82 (24.4%)

38 (26.4%)

  

Age (years)

30.35 ± 3.29

30.41 ± 3.12

0.186

0.853

SBP (mmHg)

154.17 ± 12.01

154.46 ± 12.47

0.240

0.811

DBP (mmHg)

103.25 ± 7.58

103.67 ± 8.54

0.535

0.593

BMI (kg/m²)

25.39 ± 2.92

25.41 ± 3.19

0.067

0.947

Gestational age (weeks)

36.79 ± 1.98

36.83 ± 1.71

0.211

0.833

Mode of delivery

  

0.020

0.888

Cesarean section

147 (43.8%)

64 (44.4%)

  

Vaginal delivery

189 (56.2%)

80 (55.6%)

  

Number of pregnancies

  

0.139

0.709

< 3

237 (70.5%)

104 (72.2%)

  

≥ 3

99 (29.5%)

40 (27.8%)

  

Proteinuria

  

1.700

0.192

No

101 (30.1%)

52 (36.1%)

  

Yes

235 (69.9%)

92 (63.9%)

  

Gestational diabetes mellitus

  

0.091

0.763

No

304 (90.5%)

129 (89.6%)

  

Yes

32 (9.5%)

15 (10.4%)

  

Fetal weight

  

0.011

0.915

< 4 kg

228 (67.9%)

97 (67.4%)

  

≥ 4 kg

108 (32.1%)

47 (32.6%)

  

PT (s)

13.10 ± 2.94

13.05 ± 2.58

0.177

0.860

APTT (s)

32.19 ± 4.26

32.39 ± 3.61

0.493

0.623

FIB (g/L)

2.47 ± 0.96

2.63 ± 1.11

1.595

0.111

TT (s)

13.99 ± 2.70

14.03 ± 2.55

0.151

0.880

PLT (×109/L)

202.32 ± 28.45

203.05 ± 31.35

0.250

0.803

25(OH)D (ng/mL)

29.68 ± 6.60

29.45 ± 5.67

0.364

0.716

HGF (ng/mL)

54.23 ± 10.47

55.46 ± 11.24

1.154

0.249

ET (pg/mL)

87.37 ± 11.67

87.71 ± 11.77

0.292

0.771

  1. PPH, postpartum hemorrhage; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; PT, prothrombin time; APTT, activated partial thromboplastin time; FIB, fibrinogen; TT, thrombin time; PLT, platelet count; 25(OH)D, 25-hydroxyvitamin D; HGF, hepatocyte growth factor; ET, Endothelin.